Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2009
05/14/2009US20090123905 Method of Preserving Early Embryos of Experimental Animals by Vitrification
05/14/2009US20090123904 Composition for preserving cells, tissues, or organs, production process and uses
05/14/2009US20090123575 Blended Compositions for Treatment of Alzheimer's Disease and Other Amyloidoses
05/14/2009US20090123572 Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen
05/14/2009US20090123560 Hematopoietic Stem Cell Proliferation Inducing Agent
05/14/2009US20090123511 Biomaterial derived from vertebrate liver tissue
05/14/2009US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use
05/14/2009US20090123490 Circovirus sequences associated with piglet weight loss disease (PWD)
05/14/2009US20090123489 Novel immunotherapy against neuronal and brain tumors
05/14/2009US20090123483 Anti-ccr7 receptor antibodies for the treatment of cancer
05/14/2009US20090123479 Immunoglobulins
05/14/2009US20090123478 Human antibody molecules for IL-13
05/14/2009US20090123477 Antibodies
05/14/2009US20090123476 Targeted binding agents directed to upar and uses thereof
05/14/2009US20090123475 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens
05/14/2009US20090123473 Human bnp immunospecific antibodies
05/14/2009US20090123472 Detection of mutations in a gene associated with resistance to viral infection, oas1
05/14/2009US20090123470 Antibodies Against Cancer
05/14/2009US20090123468 Transducible polypeptides for modifying metabolism
05/14/2009US20090123463 Methods and compositions for inducing apoptosis
05/14/2009US20090123462 Fgfr agonists
05/14/2009US20090123461 Human podocalyxin alternative-spliced forms and uses thereof
05/14/2009US20090123458 having a modified histidine residue with a fluorine at the 2-position so that the pKa of the modified histidine residue is less than about 3; vaccine for the treatment of anthrax
05/14/2009US20090123442 Expanded nk cells
05/14/2009US20090123441 Engineered Dendritic Cells and Uses for the Treatment of Cancer
05/14/2009US20090123437 Methods for collecting and using placenta cord blood stem cells
05/14/2009US20090123436 Cryopreservative compositions and methods
05/14/2009US20090123435 Cultured three-dimensional tissues and uses thereof
05/14/2009US20090123434 Cellular upregulation of VEGF receptor expression using nanofibrillar articles
05/14/2009US20090123433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation
05/14/2009US20090123432 Novel population of hepatocytes derived via definitive endoderm (DE-hep) from human blastocysts derived stem cells
05/14/2009US20090123431 Cell/ligand marking system, wherein the marker is of eph type, cell material comprising said system, method for preparing same and proangiogenetic use
05/14/2009US20090123430 Method for differentiation of stem cells
05/14/2009US20090123366 Targeted Therapy
05/14/2009US20090120555 Novel amylolytic enzyme extracted from Bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme
05/14/2009DE60226243T2 Peptid-bildendes Enzymgen, Pepid-bildendes Enzym und Dipeptidherstellungsverfahren Peptide-forming enzyme gene PEPID-forming enzyme and Dipeptidherstellungsverfahren
05/14/2009CA2706700A1 Compositions and methods for generating antibodies
05/14/2009CA2704556A1 West nile virus vaccine, and method for production thereof
05/14/2009CA2704232A1 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28
05/14/2009CA2703395A1 Mycobacterium antigens
05/14/2009CA2702630A1 Use of lingo-4 antagonists in the treatment of conditions involving demyelination
05/14/2009CA2692634A1 Method for isolating and culturing adult stem cells derived from human amniotic epithelium
05/13/2009EP2058395A1 Kif-derived peptide capable of binding to hla-a24 molecule
05/13/2009EP2058394A1 Method for designing mutated enzyme, method for preparing the same and mutated enzyme
05/13/2009EP2058391A1 Method for highly amplifying target gene in mammalian cell and vector therefor
05/13/2009EP2058389A1 Defined dendritic cell maturation medium comprising TNF-alpha, IL-1beta, IL-6, GM-CSF and IL-4
05/13/2009EP2058388A1 Non-conventional NKT cells for use in cancer therapy
05/13/2009EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
05/13/2009EP2058333A2 Anti-CCR2 antibodies and methods of use therefor
05/13/2009EP2058329A1 Improved secretion of neublastin
05/13/2009EP2058327A2 Genes encoding insect odorant receptors and uses thereof
05/13/2009EP2058006A1 Anti-CCR5 antibody
05/13/2009EP2057274A2 Phospholipases, nucleic acids encoding them and methods for making and using them
05/13/2009EP2057263A1 Production of fermentation products in biofilm reactors using microorganisms immobilised on sterilised granular sludge
05/13/2009EP2057178A2 Phytases, nucleic acids encoding them and methods for making and using them
05/13/2009EP2057177A2 Compositions and their uses directed to diacylglycerol acyltransferase 1
05/13/2009EP2056849A2 Methods and compositions for treating ige-mediated diseases
05/13/2009EP1937798A4 Chemically defined culture media for expansion and differentiation of epidermal cells and uses thereof for in vitro growth of hair follicles
05/13/2009EP1820023B1 Stem cells, method for their purification, identification, and use
05/13/2009EP1771549B1 Method for isolating and culturing neural stem cells
05/13/2009EP1749088A4 Expansion of neural stem cells with lif
05/13/2009EP1490490B1 Antisense iap nucleobase oligomers and uses thereof
05/13/2009EP1485477B1 Novel type-1 cytokine receptor glm-r
05/13/2009EP1483373B1 Surgical device for skin therapy or testing
05/13/2009EP1466174B1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
05/13/2009EP1381673B1 Compositions and methods useful for hcv infection
05/13/2009EP1373525B1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof
05/13/2009EP1317536B1 Tnf receptor-like molecules and uses thereof
05/13/2009EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses
05/13/2009EP1224297B1 Alzheimer's disease secretase, app substrates therefor, and uses therefor
05/13/2009EP1212405B1 Use of cytokines, cells, and mitogens to inhibit graft versus host disease
05/13/2009EP1165807B1 A protease, a gene therefor and the use thereof
05/13/2009EP1135514B1 E1b-deleted adenoviral shuttle vectors
05/13/2009EP0914325B1 Modulators of the function of fas receptors and other proteins
05/13/2009CN101432425A Method of producing insulin-secreting cells from adult stem cells via transfection
05/13/2009CN101432422A Cytotoxicity mediation of cells evidencing surface expression of TROP-2
05/13/2009CN101432421A Separation method of nucleated cells derived from bone marrow for bone formation
05/13/2009CN101432420A Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
05/13/2009CN101432419A Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
05/13/2009CN101432308A FAS binding antibodies
05/13/2009CN101432031A Conjunctival tissue system
05/13/2009CN101432020A Methods and materials for the inhibition of transplant rejection
05/13/2009CN101432018A IL-13 binding agents
05/13/2009CN101429522A Method of elevating transformation efficiency in plant by adding copper ion
05/13/2009CN101429513A RNA induced silencing complex mediated shearing site and uses thereof
05/13/2009CN101429497A In vitro cultivation method Olfactory stem cell
05/13/2009CN101429496A Culture medium for human peripheral blood source hemopoietic stem cell
05/13/2009CN101429495A Cultivation method for human peripheral blood source hemopoietic stem cell
05/13/2009CN101429494A Regulating and controlling method for inhibiting nerve stem cell differentiation with chemical group
05/13/2009CN101429493A Establishing method for parthenogenetic activation of source embryonic stem cell
05/13/2009CN101429492A Mature method for in vitro culture of porcine oocyte
05/13/2009CN101429491A Method for inducement of cynomorium songaricum succulent stem callus and special-purpose culture medium thereof
05/13/2009CN101429490A Method for inducement of cynomorium songaricum seed callus and special-purpose culture medium thereof
05/13/2009CN101429489A Cinnamomum kanahirai hay body embryo culture medium and tissue culture rapid propagation method
05/13/2009CN101429482A Cell microcarrier culture liquor relief apparatus and method
05/13/2009CN101429250A Mold toxin penicillic acid monoclone antibody and preparation method thereof
05/13/2009CN101429249A Anti-human chorionic gonadotrophin beta subunit monoclone antibody and preparation method thereof
05/13/2009CN101429248A Anti-double-chain DNA monoclone antibody with antineoplastic activity and preparation method thereof
05/13/2009CN101429246A Method for producing immunoglobulins containing protection proteins and their use
05/13/2009CN101428039A Educated nk t cells and their uses in the treatment of immune-related disorders
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 1827